DaVita
DVA
#1953
Rank
HK$79.82 B
Marketcap
HK$1,269
Share price
-6.48%
Change (1 day)
39.87%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): HK$108.65

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$108.87. In 2025 the company made an earnings per share (EPS) of HK$79.38 a decrease over its 2024 EPS that were of HK$86.52.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$108.6536.87%
2025HK$79.38-8.25%
2024HK$86.5244.94%
2023HK$59.6927.26%
2022HK$46.91-35.56%
2021HK$72.7944.1%
2020HK$50.5119.7%
2019HK$42.20540.48%
2018HK$6.59-76.07%
2017HK$27.53-19.31%
2016HK$34.12242.52%
2015HK$9.96-62.87%
2014HK$26.8313.43%
2013HK$23.658.45%
2012HK$21.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$189.51 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$96.24-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$272.26 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.79-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA